Regeneron's Trump Deal Offers Free Hearing Therapy

• Regeneron will lower US drug prices for some Americans.
• Free hearing-loss gene therapy offered to eligible patients.
• Deals are part of Trump's "most favored nation" effort on drug pricing.
• Regeneron's gene therapy, Otarmeni, restores hearing in deaf children.

Chaos Incarnate, Reporting Live

Alright, you magnificent maniacs, Jinx here, reporting live from... well, wherever the wind takes me. Today's story? Apparently, some bigwig company called Regeneron made a deal with…ugh…*him*. Yeah, you know, the one with the hair. Apparently, they're gonna lower drug prices for some folks. Because, you know, everyone loves free stuff, right? Especially when it comes from someone who probably doesn't even know how to use a Zapper.

Free Ears? Is This Real Life?

Hold on to your hats, 'cause this is where it gets interesting. These Regener-whatevers are offering *free* hearing-loss gene therapy to some lucky ducks. FREE. As in, doesn't cost ya a thing. No jinxing here, unless it's a jinx for the bad guys. They even got the FDA to approve their gene therapy, Otarmeni, restoring hearing in children. Speaking of hearing, you know what I can't hear anymore? People complaining about gas prices. Oh wait, they still do that. Maybe they should check out GOP Gas Price Panic Button Iran War Woes Fuel Election Fears

Trump's 'Most Favored Nation' Shenanigans

So, why the sudden generosity? Apparently, it's part of Trump's "most favored nation" plan. Sounds like a beauty pageant for countries, doesn't it? He wants to tie U.S. drug prices to the lowest ones in other developed nations. It's all about the Benjamins, baby. He's exempting the companies from tariffs for three years, including Trump's planned levies on some pharmaceutical products. What's next? Is he gonna start offering free rockets to the moon?

Seventeen Deals and Counting?

CMS deputy administrator Chris Klomp (try saying that five times fast) claims the Trump administration has already made 17 deals like this. SEVENTEEN. I can barely keep track of how many bullets I've fired today. They're supposedly negotiating with more companies too. It's like a Black Friday sale, but for healthcare. What a day to be alive, don't ya think?

Otarmeni: The Miracle Cure (Maybe)

This fancy new gene therapy, Otarmeni, apparently got fast-tracked by the FDA. Targets some super rare genetic thingy that makes kids deaf. Before you know it, those little ankle biters will be able to hear me screaming through a megaphone. It's a significant breakthrough for a subset of patients who have long depended on cochlear implants. The analysts are already saying it's gonna rake in $130 million. Cha-ching.

Jinx Out!

So there you have it, folks. Deals, discounts, and maybe even a little hope for the future. Will it actually work? Who knows. But hey, at least it's something to blow up… er, *ponder* over. Jinx out!